'Targeted & immunotherapy combination has demonstrated improved survival in RCC'

'Targeted & immunotherapy combination has demonstrated improved survival in RCC' World Kidney Cancer Day: Renal cell carcinoma (RCC) is generally resistant to traditional chemotherapy and radiation therapy. It is crucial that patients with advanced or metastatic kidney cancer receive systemic therapy that includes targeted therapy and immunotherapy. https://ift.tt/G9lg5Ho